Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,610.00
Bid: 1,610.00
Ask: 1,610.50
Change: -6.50 (-0.40%)
Spread: 0.50 (0.031%)
Open: 1,619.50
High: 1,622.50
Low: 1,610.00
Prev. Close: 1,616.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London pre-open: FTSE called to open lower ahead of Fed and BoE minutes

Wed, 20th Nov 2013 07:33

City sources predict the FTSE 100 will open around 21 points lower than yesterday's close of 6,698.01, ahead of the release of the minutes from both the Bank of England and the latest meeting of the US Federal Reserve. The Federal Open Market Committee's meeting should offer further insight behind the Fed's decision to maintain its monetary stimulus programme. Last month the Fed said it would keep interest rates near zero and its monthly $85bn bond buying programme unchanged until the economy and jobs market improved further. The President of the Federal Reserve Bank of New York said on Monday that he was "getting more hopeful" about the economic recovery, citing labour market improvements and stronger-than-expected growth in the third quarter."Given that he is typically dovish, these comments have been taken by investors as a warning that the Fed will soon begin to wind down its asset purchase program," said Craig Erlam, Market Analyst at Alpari UK, yesterday.This morning he added: "It was no surprise when the Fed left policy unchanged last month, but investors will be looking for hints about when policy makers intend to taper. If there is still a lot of support for tapering this year, it could lead to a December taper being heavily priced in, especially if this is paired with data that suggests the economy was unaffected by the shutdown." Elsewhere, Philadelphia Fed President Charles Plosser said the Fed should set a fixed dollar amount on its monetary easing and end bond purchases when that amount is reached."We cannot continue to play this bond-buying game by ear and risk the Fed's credibility while creating lingering uncertainty about the course of monetary policy," he said in a speech before the Risk Management Association in Philadelphia.Many economists expect the Fed to announce a tapering of quantitative easing to $70bn a month in March, although uncertainty remains.Today's agenda will also be jam packed with economic data with the release of US retail sales, manufacturing inventories and mortgage applications. Back on this side of the Pond, the Bank of England will release minutes of its interest rate decision. The central bank last month announced it would keep interest rates at 0.5% and asset purchases at £375bn. Investors will today be looking to see if the BoE has shown any signs that policy makers favour a new unemployment threshold. In company news, infrastructure investor HICL Infrastructure said net asset value rose 3.2p per share for the first half of its financial year and said the pipeline of potential new investment opportunities under evaluation remains promising. NAV per share, post-interim dividend, rose to 119.6p from 116.4p at March 31st.GlaxoSmithKline has completed the partial sale of Aspen Pharmacare, the drug company announced this morning. The group has disposed 28.2m ordinary shares in Aspen at a price of 250 South African Rand (ZAR) per share, raising gross proceeds of 7,059 ZAR.Utilities reseller Telecom Plus has completed an acquisition of Npower's gas and electricity supply businesses that catapults it into big league of UK utilities. The FTSE 250 company, which operates via the Utility Warehouse brand and uses customers as distributors, has agreed a price of £218m, which it will fund via a share placing and new debt.NR
More News
18 Sep 2023 07:18

US FDA approves GSK treatment for myelofibrosis

(Sharecast News) - GSK announced on Monday that the US Food and Drug Administration (FDA) has granted approval for 'Ojjaara', or momelotinib, as a treatment for adults suffering from intermediate or high-risk myelofibrosis with anaemia, including cases of primary myelofibrosis or secondary myelofibrosis.

Read more
15 Sep 2023 21:52

GSK's Ojjaara approved in US for myelofibrosis patients with anaemia

(Alliance News) - GSK PLC on Friday said Ojjaara, also known as momelotinib, has been approved in the US and the "first and only" treatment indicated for myelofibrosis patients with anaemia.

Read more
11 Sep 2023 08:24

Japan accepts GSK's regulatory filing for momelotinib for blood cancer

(Alliance News) - GSK PLC on Monday reported regulatory progress for momelotinib, as Japan's Ministry of Health, Labour & Welfare accepted a review for the blood cancer-focused drug.

Read more
11 Sep 2023 07:54

LONDON BRIEFING: Restaurant Group sells Frankie & Benny's and Chiquito

(Alliance News) - Stocks in London are called higher on Monday, ahead of a busy week of interest rate decisions and economic data.

Read more
6 Sep 2023 09:32

LONDON BROKER RATINGS: Shore says 'buy' B&M; Peel Hunt likes Halfords

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
4 Sep 2023 06:00

More UK babies to need hospital treatment over delay of GSK's RSV jab

(Alliance News) - The nation's top children's doctor has warned a delay on a new vaccine to combat respiratory syncytial virus, or RSV, will mean more babies and infants will need hospital treatment this winter.

Read more
1 Sep 2023 09:11

GSK antibody accepted for Japan review, Goldman Sachs reduces stake

(Alliance News) - GSK PLC on Friday said a new drug application for its monoclonal antibody mepolizumab has been accepted for review by the Japanese government.

Read more
1 Sep 2023 07:49

LONDON BRIEFING: Stocks seen higher; UK house prices continue to fall

(Alliance News) - Stocks in London are set to open higher on Friday as markets looked ahead to a data-heavy day.

Read more
1 Sep 2023 07:12

Japan considering GSK's Nucala drug for sinusitis treatment

(Sharecast News) - Japanese regulators are reviewing a new drug application for GSK's Nucala treatment to be used for the treatment of form of adult sinusitis, the biopharma giant announced on Friday.

Read more
23 Aug 2023 12:10

LONDON MARKET MIDDAY: Stocks rise but pound slumps on sub-par UK data

(Alliance News) - Stocks in Europe were on the up heading into Wednesday afternoon, with equity markets in a confident mood on the eve of the Jackson Hole central banking event, shaking off tepid economic data which hurt the pound and euro.

Read more
23 Aug 2023 08:17

GSK gets positive results from shingles trial of Shingrix in China

(Alliance News) - GSK PLC on Wednesday celebrated positive results from the first-ever efficacy trial of its preventative shingles treatment, Shingrix, in China.

Read more
23 Aug 2023 07:04

GSK reports positive results from shingles vaccine trials in China

(Sharecast News) - GSK reported significant positive findings from its first efficacy trial of the 'Shingrix' shingles vaccine in China on Wednesday.

Read more
22 Aug 2023 13:09

UK's Wood Group raises profit forecast on contract wins; shares rise

CFO David Kemp to retire

*

Read more
21 Aug 2023 22:37

US FDA approves Pfizer's maternal RSV vaccine to protect infants

Aug 21 (Reuters) - The U.S. Food and Drug Administration on Monday approved Pfizer's respiratory syncytial virus (RSV) vaccine for use in women during the middle of the third trimester of pregnancy to protect their babies.

Read more
17 Aug 2023 19:53

Charity says HIV drug deal with GSK's ViiV on ice over price secrecy

(Alliance News) - The Doctors Without Borders, or MSF, charity said Thursday a deal aimed to bring long-term preventative HIV treatment to vulnerable populations was on hold after the drugmaker imposed pricing confidentiality.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.